Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Mounjaro and Zepbound just handed Lilly a blowout quarter, but falling realized drug prices and one-time revenue boosts that won't repeat raise real questions about whether the rally holds from here.
Directly affected
- LLY Eli Lilly+14.3% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.
- JNJ Johnson & Johnson+3.3% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- PFE Pfizer+2.3% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- MRK Merck+3.4% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
- ABBV AbbVie+9.3% 30d
AbbVie (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LLY | -9.71% | -8.92% | base | +0.15% | -0.54% | +0.07% | -3.00% |
| XLV | -3.03% | -2.77% | base | -0.14% | -0.48% | +2.59% | +0.17% |
| XBI | -3.49% | +0.99% | base | -2.51% | -0.66% | +2.01% | -4.85% |
| JNJ | -2.53% | -0.72% | base | -0.98% | -2.59% | +1.13% | -0.32% |
| PFE | -2.33% | -3.34% | base | +0.69% | -1.70% | +0.95% | -2.03% |
| MRK | -5.94% | -5.65% | base | -0.74% | -3.26% | +0.55% | -1.48% |
| ABBV | -2.71% | -2.90% | base | -2.03% | -3.03% | -0.45% | -1.91% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now? 24/7 Wall St.
Source: 24/7 Wall St.
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | -2.03% | final price |
| ABBV | the next day | -3.03% | final price |
| ABBV | two days later | -0.45% | final price |
| ABBV | three days later | -1.91% | final price |
| ABBV | three days earlier | -2.90% | final price |
| ABBV | five days earlier | -2.71% | final price |
| JNJ | that day | -0.98% | final price |
| JNJ | the next day | -2.59% | final price |
| JNJ | two days later | +1.13% | final price |
| JNJ | three days later | -0.32% | final price |
| JNJ | three days earlier | -0.72% | final price |
| JNJ | five days earlier | -2.53% | final price |
| LLY | that day | +0.15% | final price |
| LLY | the next day | -0.54% | final price |
| LLY | two days later | +0.07% | final price |
| LLY | three days later | -3.00% | final price |
| LLY | three days earlier | -8.92% | final price |
| LLY | five days earlier | -9.71% | final price |
| MRK | that day | -0.74% | final price |
| MRK | the next day | -3.26% | final price |
| MRK | two days later | +0.55% | final price |
| MRK | three days later | -1.48% | final price |
| MRK | three days earlier | -5.65% | final price |
| MRK | five days earlier | -5.94% | final price |
| PFE | that day | +0.69% | final price |
| PFE | the next day | -1.70% | final price |
| PFE | two days later | +0.95% | final price |
| PFE | three days later | -2.03% | final price |
| PFE | three days earlier | -3.34% | final price |
| PFE | five days earlier | -2.33% | final price |
| XBI | that day | -2.51% | final price |
| XBI | the next day | -0.66% | final price |
| XBI | two days later | +2.01% | final price |
| XBI | three days later | -4.85% | final price |
| XBI | three days earlier | +0.99% | final price |
| XBI | five days earlier | -3.49% | final price |
| XLV | that day | -0.14% | final price |
| XLV | the next day | -0.48% | final price |
| XLV | two days later | +2.59% | final price |
| XLV | three days later | +0.17% | final price |
| XLV | three days earlier | -2.77% | final price |
| XLV | five days earlier | -3.03% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?” scores 12 out of 100. The score uses 1 sources.